As shown in Figure 2, previous studies have shown that Piezo1 is highly expressed in glioma, and its expression is negatively correlated with patient survival (Chen et al., 2018; Qu et al., 2020b; Zhou et al., 2020). This evidence concerns the gene PIEZO1 and central nervous system cancer.